Drug intelligence / Profile preview

XiaoErXiaoZhi formula

Development stage: Unknown
Lead developer: Beijing Hepingli Hospital
Administration: Oral

Overview

XiaoErXiaoZhi formula is a Traditional Chinese Medicine (TCM) herbal combination developed by Beijing Hepingli Hospital for the treatment of simple obesity in children. It is specifically indicated for patients presenting with the TCM syndrome of "spleen deficiency and dampness." The formula is designed to tonify the spleen, resolve dampness, and regulate metabolic functions. It is currently being evaluated in a multi-center, randomized, double-blind, placebo-controlled clinical trial (ChiCTR2300068485) to assess its efficacy, safety, and impact on gut microbiota composition in children aged 7 to 14 years. The treatment aims to address pediatric weight gain by modulating metabolic pathways and restoring microbial balance in the gut.

Other names: Xiaoer Xiaozhi formula

Beyond the preview

Go deeper on XiaoErXiaoZhi formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiaoErXiaoZhi formula.

Explore the full profile